Cargando…

Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours

BACKGROUND: Overexpression of carbonic anhydrase (CA IX) is associated with poor survival in several adult-type cancers but its expression is undocumented in Wilms tumour (WT), the most common tumour of the paediatric kidney. METHODS: CA9 expression was measured using polymerase chain reaction (PCR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Dungwa, Josiah V, Hunt, Linda P, Ramani, Pramila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224349/
https://www.ncbi.nlm.nih.gov/pubmed/21910893
http://dx.doi.org/10.1186/1471-2407-11-390
_version_ 1782217364419379200
author Dungwa, Josiah V
Hunt, Linda P
Ramani, Pramila
author_facet Dungwa, Josiah V
Hunt, Linda P
Ramani, Pramila
author_sort Dungwa, Josiah V
collection PubMed
description BACKGROUND: Overexpression of carbonic anhydrase (CA IX) is associated with poor survival in several adult-type cancers but its expression is undocumented in Wilms tumour (WT), the most common tumour of the paediatric kidney. METHODS: CA9 expression was measured using polymerase chain reaction (PCR) in 13 WTs and matched-paired non-neoplastic kidneys (NKs). CA IX and hypoxia-inducible factor-1 α-subunit (HIF-1α) protein were quantified in 15 matched-paired WTs and NKs using enzyme-linked immunosorbent assays. CA IX and HIF-1α were localised by immunostaining tissue sections of 70 WTs (untreated WTs, n = 22; chemotherapy-treated WTs, n = 40; relapsed/metastatic WTs, n = 8). CA IX-positive untreated WTs (n = 14) were immunostained for vascular endothelial growth factor (VEGF), glucose transporter-1 (GLUT1) and CD31. Double staining for CA IX and CD31 was performed in WTs (n = 14). RESULTS: CA9 full length (FL) was significantly up-regulated in WTs compared to NKs (p = 0.009) by real-time PCR. Conventional PCR showed expression of alternative splice variant in all NKs and WTs but FL in WTs only. WTs showed a 2-fold increase in CA IX protein over NKs (p = 0.01). HIF-1α levels were up-regulated in WTs compared to NKs, although the difference was not statistically significant (p = 0.09). CA IX and HIF-1α immunolocalisation were observed in 63% and 93% of WTs, respectively. The median fraction of cells staining positively for CA IX and HIF-1α was 5% and 22%, respectively. There was no significant association between the expression of either CA IX or HIF-1α and clinicopathological variables in WTs resected following chemotherapy. VEGF and GLUT1 immunoreactivity was seen in 94% and 100% with the median fraction of 10% and 60% respectively. Co-expression and co-localisation of all four hypoxia markers was seen in 7/14 and 6/14 cases respectively. CA IX was seen in well vascularised areas as well as in the peri-necrotic areas. CONCLUSIONS: Carbonic anhydrase 9 (mRNA and protein), and HIF-1α protein are overexpressed in a significant portion of WTs. No significant association was detected between the expression of either CA IX or HIF-1α and clinicopathological variables in WTs resected following chemotherapy. Cellular localisation studies in untreated WTs suggest that CA IX and HIF-1α are regulated by hypoxia and non-hypoxia mechanisms.
format Online
Article
Text
id pubmed-3224349
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32243492011-11-27 Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours Dungwa, Josiah V Hunt, Linda P Ramani, Pramila BMC Cancer Research Article BACKGROUND: Overexpression of carbonic anhydrase (CA IX) is associated with poor survival in several adult-type cancers but its expression is undocumented in Wilms tumour (WT), the most common tumour of the paediatric kidney. METHODS: CA9 expression was measured using polymerase chain reaction (PCR) in 13 WTs and matched-paired non-neoplastic kidneys (NKs). CA IX and hypoxia-inducible factor-1 α-subunit (HIF-1α) protein were quantified in 15 matched-paired WTs and NKs using enzyme-linked immunosorbent assays. CA IX and HIF-1α were localised by immunostaining tissue sections of 70 WTs (untreated WTs, n = 22; chemotherapy-treated WTs, n = 40; relapsed/metastatic WTs, n = 8). CA IX-positive untreated WTs (n = 14) were immunostained for vascular endothelial growth factor (VEGF), glucose transporter-1 (GLUT1) and CD31. Double staining for CA IX and CD31 was performed in WTs (n = 14). RESULTS: CA9 full length (FL) was significantly up-regulated in WTs compared to NKs (p = 0.009) by real-time PCR. Conventional PCR showed expression of alternative splice variant in all NKs and WTs but FL in WTs only. WTs showed a 2-fold increase in CA IX protein over NKs (p = 0.01). HIF-1α levels were up-regulated in WTs compared to NKs, although the difference was not statistically significant (p = 0.09). CA IX and HIF-1α immunolocalisation were observed in 63% and 93% of WTs, respectively. The median fraction of cells staining positively for CA IX and HIF-1α was 5% and 22%, respectively. There was no significant association between the expression of either CA IX or HIF-1α and clinicopathological variables in WTs resected following chemotherapy. VEGF and GLUT1 immunoreactivity was seen in 94% and 100% with the median fraction of 10% and 60% respectively. Co-expression and co-localisation of all four hypoxia markers was seen in 7/14 and 6/14 cases respectively. CA IX was seen in well vascularised areas as well as in the peri-necrotic areas. CONCLUSIONS: Carbonic anhydrase 9 (mRNA and protein), and HIF-1α protein are overexpressed in a significant portion of WTs. No significant association was detected between the expression of either CA IX or HIF-1α and clinicopathological variables in WTs resected following chemotherapy. Cellular localisation studies in untreated WTs suggest that CA IX and HIF-1α are regulated by hypoxia and non-hypoxia mechanisms. BioMed Central 2011-09-12 /pmc/articles/PMC3224349/ /pubmed/21910893 http://dx.doi.org/10.1186/1471-2407-11-390 Text en Copyright ©2011 Dungwa et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dungwa, Josiah V
Hunt, Linda P
Ramani, Pramila
Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours
title Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours
title_full Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours
title_fullStr Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours
title_full_unstemmed Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours
title_short Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours
title_sort overexpression of carbonic anhydrase and hif-1α in wilms tumours
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224349/
https://www.ncbi.nlm.nih.gov/pubmed/21910893
http://dx.doi.org/10.1186/1471-2407-11-390
work_keys_str_mv AT dungwajosiahv overexpressionofcarbonicanhydraseandhif1ainwilmstumours
AT huntlindap overexpressionofcarbonicanhydraseandhif1ainwilmstumours
AT ramanipramila overexpressionofcarbonicanhydraseandhif1ainwilmstumours